Mark Lapre
Controller at Karuna Therapeutics
Boston, Massachusetts, United States
Professional Overview
Mark Lapre is an accomplished finance and accounting professional with over 13 years of experience in the biotech and pharmaceutical industries. As the Controller at Karuna Therapeutics, he is responsible for overseeing the company's financial reporting, budgeting, and internal control processes, contributing to the organization's strategic growth and operational efficiency.
Experience Summary
Current Role
As the Controller at Karuna Therapeutics, Mark is responsible for managing the company's day-to-day accounting operations, including financial reporting, budgeting, and forecasting. He plays a critical role in ensuring the accuracy and integrity of Karuna's financial records, contributing to the organization's strong financial position and supporting its mission to develop innovative therapies.
Career Progression
Prior to his current role, Mark served as an Assurance Manager at RSM US LLP, where he led audit engagements for clients in the biotech and pharmaceutical sectors. Before that, he worked as an Audit Senior at Deloitte & Touche, honing his skills in financial reporting, internal controls, and regulatory compliance. Mark's diverse experience and deep industry knowledge have been instrumental in his success, enabling him to drive meaningful impact throughout his career.
Academic Background
Mark holds a Bachelor of Science degree in Accounting from the University of Massachusetts Amherst. He is a Certified Public Accountant (CPA) and has demonstrated a commitment to continuous learning and professional development.
Areas of Expertise
- Financial reporting and analysis
- Budgeting and forecasting
- Internal control systems
- Regulatory compliance and audit management
- Strategic financial planning and decision-making
- Team leadership and collaboration
Professional Impact
At Karuna Therapeutics, Mark has been instrumental in streamlining the company's financial processes, enhancing the accuracy and transparency of financial reporting, and supporting the organization's growth and expansion. He has played a key role in securing funding and managing financial resources to facilitate the development of Karuna's innovative drug candidates.
Conclusion
With his extensive experience in the biotech and pharmaceutical industries, strong technical skills, and demonstrated leadership abilities, Mark Lapre is a valuable asset to Karuna Therapeutics. He is committed to driving the company's financial success and contributing to its mission of improving patient outcomes through the development of groundbreaking therapies.
